Mohammed Al Kanan: Advancing Therapeutic Drug Monitoring in Pediatric Aplastic Anemia
Mohammed Al Kanan, Director of Research and Studies at Ministry of Health Saudi Arabia, shared a post on LinkedIn about a recent article by Qian Xu et al. published in Frontiers in Pediatrics, adding:
“Pleased to see another manuscript I had the opportunity to peer review in July now officially published in Frontiers in Pediatrics:
‘Correlation analysis of cyclosporine A trough concentration with hematological and biochemical parameters: a retrospective study in pediatric aplastic anemia.’
This study explored an important aspect of therapeutic drug monitoring (TDM) in pediatric aplastic anemia, examining the relationship between cyclosporine A trough concentrations and routinely available hematological, hepatic, and renal markers.
One of the most interesting findings was the significant relationship between CsA exposure and blood urea nitrogen (BUN), particularly during the first three months of therapy, suggesting that BUN may help reflect early renal hemodynamic effects and reinforce the importance of close renal monitoring during CsA treatment.
The study also reminds us that drug concentration alone does not tell the whole clinical story. Hematological recovery was not consistently correlated with CsA trough concentrations, highlighting the complexity of treatment response and the importance of individualized monitoring.
Proud to contribute to the scientific process from the reviewer’s side and to support research that advances safer, more individualized pharmacotherapy in pediatric patients.”
Title: Correlation analysis of cyclosporine A trough concentration with hematological and biochemical parameters: a retrospective study in pediatric aplastic anemia
Authors: Qian Xu, Xintong Mao, Yi Yun, Ling Liu
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!
-
Sep 28, 2026, 19:07Dhargam Aljebouri: AIHA Subclassification Research Presented at the 14th Iraqi Society of Hematology Conference
-
Sep 28, 2026, 19:02William Wallace: Your Cholesterol Test is Missing a Particle that May Matter More than the One it Measures
-
Sep 28, 2026, 18:57Indu Thakur: Honoring Sickle Warriors and Advancing Diverse Blood Donation at Sickle Ball 2026
-
Sep 28, 2026, 18:48Orly Leiva: Rethinking JAK Inhibitor Cardiovascular Safety in MPNs
-
Sep 28, 2026, 18:42Wael Saad: Honored to Be Part of Portal and Mesenteric Vein Thrombosis Session at CIRSE 2026
-
Sep 28, 2026, 18:35Alejandro González Veliz: The Unbroken Connection Between Heart and Brain
-
Sep 28, 2026, 16:43Scott Sutton: Community and Connection in Immune Thrombocytopenia
-
Sep 28, 2026, 16:24Pankti Solanki: ISBT Recognized JAMA as the 49th Human Blood Group System